Caerus Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.1M Sell
16,326
-2,237
-12% -$262K 0.7% 25
2026
Q1
$2.23M Sell
18,563
-22
-0.1% -$2.54K 0.93% 18
2025
Q4
$1.96M Buy
18,585
+2,963
+19% +$278K 0.63% 22
2025
Q3
$1.31M Buy
+15,622
New +$1.29M 0.54% 26
2023
Q2
Sell
-1,963
Closed -$209K 44
2023
Q1
$209K Hold
1,963
0.24% 49
2022
Q4
$218K Buy
+1,963
New +$201K 0.33% 38

Other funds holding MRK

Caerus Investment Advisors's MRK Position: Q2 2026 in Review

Caerus Investment Advisors reduced its Merck (MRK) stake by 12% in Q2 2026, selling an estimated $262K and leaving 16,326 shares worth $2.1M. The position accounts for 0.7% of the portfolio, ranked #25.

Caerus Investment Advisors first reported a position in MRK in Q4 2022 and has held it in 6 quarters since. The position peaked at $2.23M in Q1 2026. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Caerus Investment Advisors held 16,326 shares of Merck worth $2.1M as of Q2 2026.
  • Caerus Investment Advisors sold 2,237 Merck shares in Q2 2026, an estimated $262K.
  • Merck made up 0.7% of Caerus Investment Advisors's portfolio in Q2 2026, its #25 holding.
  • Caerus Investment Advisors first reported a position in Merck in Q4 2022 and has held it in 6 quarters since.
  • Caerus Investment Advisors's Merck position peaked at $2.23M in Q1 2026.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Caerus Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.